Promoter holding
64.27%
UI
Unicure India Ltd - Due diligence report
A 360° intelligence report on Unicure India Ltd: trust score, financial health, credit view, compliance, directors, growth and distress sign…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Unicure India Ltd — 360° Intelligence Report
Generated from MCA filings & public records79/100
Trust Score
Low Risk
Unicure India Ltd is assessed as Low Risk with a Trust Score of 79/100. Unicure India Ltd is an active public limited indian non-government company incorporated in 1980, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.
Report generated on 25 Jul 2026 from the latest processed filings. Unicure India Ltd snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
79/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
42/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 55/100 Moderate
- Liabilities ≈ 38% EBITDA - stretched.
- Open charges exceed net worth - secured lenders rank ahead.
- Moderate gearing (D/E 1.42).
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 9 open (187.15 cr) · 11 satisfied (6.22 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Canara Bank | 12 | 48.0 cr |
| Hdfc Bank Limited | 5 | 48.0 cr |
| Others | 2 | 48.0 cr |
| U. P. F. C. | 1 | 48.0 cr |
Compliance Score: 42/100 Caution Indicated
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Flagged by authority: CDSL.
- Litigation present in 3 court forum(s).
- Delayed payments to MSME suppliers disclosed (47 disclosure(s)).
- 5 active GST registration(s).
Legal cases on record (3)
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| AMIN UL AZIZ | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| QAZI SALIM RIAZ | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ABDUL MATEEN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Kashish Aziz | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Mohd Zubair | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 5 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2024 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
2 allotment(s) · 1 transfer(s)
Promoters hold the largest single block of equity - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Sojourner Bpo Private Limited | Subsidiary Company | 74.00% |
Key managerial personnel: ABDUL MATEEN (Managing Director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 95 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Latest year revenue grew 24%.
Profit expanded 0.86 year-on-year.
Net margin improved to 61%.
EPFO headcount growing - hiring signal.
Operating for 46+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Compliance score is weak (42/100).
9 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 5.44 cr.
3 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence68/100
Review suggested
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- No distress signals on file.
- Financial filings available for verification.
Banker assessment64/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 9 open charge(s) of 187.15 cr already registered.
- Compliance gaps should be priced into terms.
Investor view91/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 5 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events30 Sep 2025
Last AGM held
Annual general meeting
17 Jun 2025
Charge created
Hdfc Bank Limited - 45.00 Lakh
13 Jun 2025
Charge created
Hdfc Bank Limited - 23.05 Lakh
31 Mar 2025
Latest balance sheet
Filed with ROC
30 Dec 2024
Director appointed
AMIN UL AZIZ (Director)
Director appointed
Kashish Aziz (Director)
Director appointed
Mohd Zubair (Director)
01 Oct 2024
Charge created
Hdfc Bank Limited - 38.94 Lakh
03 Aug 2024
Director appointed
QAZI SALIM RIAZ (Director appointed in casual vacancy)
17 May 2024
Charge created
Others - 25.00 Lakh
16 Mar 2024
Charge created
Others - 50.00 Lakh
22 Nov 2022
Charge created
Hdfc Bank Limited - 17.00 Lakh
27 Aug 2021
Charge created
Canara Bank - 16.00 Lakh
16 Jan 2021
Charge created
Hdfc Bank Limited - 43.00 cr
30 Sep 2019
Director ceased
FARZANA MATEEN
10
Key Observations
Auto-generated from the data aboveRevenue grew 38% over the last 4 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
Debt-to-equity stands at 24% - manageable leverage.
Net worth is positive.
5 active director(s) / partner(s); board looks stable and experienced.
5 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold the largest single block of equity as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Panacea Biotec | L33117PB1984PLC022350 | Lalru, Punjab, India |
| Hetero Biopharma | U24290TG2016PLC111946 | Balanagar, Telangana, India |
| Skymap | U24233DL2006PTC150088 | New Delhi, Delhi, India |
| Torque Pharmaceuticals | U24119CH1986PTC007151 | Chandigarh, Chandigarh, India |
| Aristo Laboratories Private Limited | U24110MH1980PTC266205 | Mumbai, Maharashtra, India |
| Lords Mark | U21001MH1998PLC115601 | Mumbai, Maharashtra, India |
| Milan Laboratories (India) | U24230MH2003PTC139736 | Thane, Maharashtra, India |
| Cropnosys India | U24129KA2006PTC158618 | Bangalore, Karnataka, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Unicure India Ltd before audits and certifications: compliance score 42/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Unicure India Ltd: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Unicure India Ltd - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 79/100, distress signals and MSME payment-delay disclosures - know whether Unicure India Ltd pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for Unicure India Ltd - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Unicure India Ltd an active company?
Unicure India Ltd has MCA status “Active” with a compliance score of 42/100 (Caution Indicated).
Is Unicure India Ltd financially healthy?
Unicure India Ltd has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.
Should I do business with Unicure India Ltd?
Its overall Trust Score is 79/100 (Low Risk). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Unicure India Ltd?
Promoters hold the largest single block of equity - exact percentages are in the full report. 5 active director(s) are on record.
Does Unicure India Ltd have loans or charges against its assets?
9 open charge(s) are registered against its assets, and 11 earlier charge(s) stand satisfied.
Is Unicure India Ltd up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 42/100 (Caution Indicated).
Is it risky to lend to Unicure India Ltd?
Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
